Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 62 for:    somatostatin receptor | Neuroendocrine Tumors

Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03673943
Recruitment Status : Completed
First Posted : September 17, 2018
Last Update Posted : July 23, 2019
Sponsor:
Information provided by (Responsible Party):
Radiomedix, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 23, 2019
  Actual Study Completion Date : March 23, 2019